Core Insights - FOXO Technologies Inc. has outlined its key milestones for 2025 and its future growth strategy, emphasizing the foundation laid in mid-2024 through acquisitions of Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. [1] - The company has expanded its healthcare portfolio with the acquisition of Vector BioSource, Inc., positioning itself as a player in the pharmaceutical services sector [4] Myrtle Recovery Centers - Myrtle Recovery Centers has established itself as a leading provider of residential and medically supervised withdrawal treatment services for substance use disorders in Tennessee since its opening in August 2023 [2] - The Oneida facility has maintained a 93% occupancy rate with an average daily census of 28, significantly up from 7.4 in 2024 [2] - Projected patient admissions for 2025 are 550, a substantial increase from 195 in 2024 [2] - Myrtle has received funding from the State of Tennessee Opioid Abatement Fund for treating uninsured patients and is developing a mobile application called "Evana" to enhance post-discharge patient care [2] Rennova Community Health - Scott County Community Hospital, also known as Big South Fork Medical Center, serves as FOXO's flagship acute care hospital, providing a range of services including inpatient, outpatient, and emergency care [3] - The hospital is projected to see over 7,000 ER patients, 3,500 outpatient visits, and 300 inpatient stays in 2025 [5] - Recently added services include swing bed and wound care, and the hospital is in-network with all major payors [5] Vector BioSource - The acquisition of Vector BioSource is expected to generate approximately $1 million in net revenues for 2025, with anticipated significant growth as the company invests in infrastructure and market expansion [4][6] - Vector specializes in sourcing biospecimens for the biotechnology and pharmaceutical research sectors [4] Corporate and Growth Outlook - The company has settled several legacy liabilities and strengthened its management team, with equity increasing from $5.3 million at the end of 2024 to $20.2 million by September 30, 2025 [7][12] - Debt has been reduced from $10.2 million at the end of 2024 to $7.1 million by September 30, 2025 [12] - FOXO has formed a wholly owned subsidiary, FOXO Acquisition Corporation, to facilitate acquisitions and has introduced a new series of preferred stock [7] - The company aims to uplist its common stock to NYSE American or another recognized exchange, although there is no certainty regarding this goal [8]